Objectives In the Fluid and Catheter Treatment Trial (FACTT) of the National Institutes of Health Acute Respiratory Distress Syndrome Network, a conservative fluid protocol (FACTT Conservative) resulted in a lower cumulative fluid balance and better outcomes than a liberal fluid protocol (FACTT Liberal). Subsequent Acute Respiratory Distress Syndrome Network studies used a simplified conservative fluid protocol (FACTT Lite). The objective of this study was to compare the performance of FACTT Lite, FACTT Conservative, and FACTT Liberal protocols. Design Retrospective comparison of FACTT Lite, FACTT Conservative, and FACTT Liberal. Primary outcome was cumulative fluid balance over 7 days. Secondary outcomes were 60-day adjusted mortality and ventilator-free days through day 28. Safety outcomes were prevalence of acute kidney injury and new shock. Setting ICUs of Acute Respiratory Distress Syndrome Network participating hospitals. Patients Five hundred three subjects managed with FACTT Conservative, 497 subjects managed with FACTT Liberal, and 1,124 subjects managed with FACTT Lite. Interventions Fluid management by protocol. Measurements and Main Results Cumulative fluid balance was 1,918 ± 323 mL in FACTT Lite, −136 ±491 mL in FACTT Conservative, and 6,992 ± 502 mL in FACTT Liberal (p < 0.001). Mortality was not different between groups (24% in FACTT Lite, 25% in FACTT Conservative and Liberal, p = 0.84). Ventilator-free days in FACTT Lite (14.9 ±0.3) were equivalent to FACTT Conservative (14.6±0.5) (p = 0.61) and greater than in FACTT Liberal (12.1 ±0.5, p < 0.001 vs Lite). Acute kidney injury prevalence was 58% in FACTT Lite and 57% in FACTT Conservative (p = 0.72). Prevalence of new shock in FACTT Lite (9%) was lower than in FACTT Conservative (13%) (p = 0.007 vs Lite) and similar to FACTT Liberal (11%) (p = 0.18 vs Lite). Conclusions FACTT Lite had a greater cumulative fluid balance than FACTT Conservative but had equivalent clinical and safety outcomes. FACTT Lite is an alternative to FACTT Conservative for fluid management in Acute Respiratory Distress Syndrome.
By increasing the understanding of the characteristics and limitations of the oscillometric method and the effects of waveform shape on pressure measurements, simulator evaluation should lead to improvements in NIBP devices.
The systolic and diastolic paired oscillometric-auscultatory pressure differences varied with their corresponding characteristic ratios. Good agreement (within 5 mmHg) between the oscillometric and auscultatory pressures occurred for oscillometric pulse amplitude envelopes with specific ranges of characteristic ratios, but the ranges were different for the two devices. Further work is required to classify the different envelope shapes, comparing them with patient conditions, to determine if a clearer understanding of the different waveform shapes would improve the accuracy of oscillometric measurements.
The sounds associated with the five classical Korotkoff phases are clinically important for measuring systolic and diastolic blood pressures. The frequency ranges of the sounds have already been described simply using the overall peak frequencies within each phase by Fourier methods. However, such analysis may be missing potentially useful clinical information. The aim of this study was to compare features associated with the different phases of the Korotkoff sounds obtained during blood pressure measurement using a joint time-frequency analysis (JTFA) technique. A single operator recorded Korotkoff sounds from 25 healthy subjects using a measurement system comprising cardiology stethoscope, microphone, amplifier and recording system for computer sound digitization, and a MiniDisc system for playback to the cardiologist for Korotkoff phase classification. We have shown that using this system the phase classification by the cardiologist is repeatable, with no significant differences found in the number of sounds allocated to phases on two separate recording assessments. The digitized sounds were processed using a MATLAB-based short-time Fourier transform JTFA technique and differences in time, frequency and amplitude characteristics between the phases compared. It was found that on average, phase III had the largest overall amplitude and high frequency energy. Phase II had the greatest high frequency component and longest murmur, and was visibly the most complex phase in terms of time and frequency content. In contrast, phases IV and V had the lowest amplitude and frequency components. Overall, the statistically significant transitions between phases were: phase I to II with increases in high frequency (224 to 275 Hz) (p < 0.01) and sound duration (49 to 98 ms) (p < 0.0001), II to III with a significant decrease in sound duration (to 37 ms) (p < 0.0001), III to IV with decreases in maximum amplitude (0.95 to 0.25), highest frequency (262 to 95 Hz), and relative high frequency energy of the sounds (0.61 to 0.10) (all p < 0.0001), and IV to V with decreases in the maximum amplitude (0.25 to 0.13) (p < 0.0002) and high frequency energy (0.10 to 0.03) (p < 0.005). This study has demonstrated that joint time-frequency analysis of Korotkoff sounds was able to identify characteristic differences associated with the different phases classified by the expert cardiologist. Ultimately, exploiting the joint time and frequency characteristics of the sounds may improve blood pressure measurement and help to assess the stiffness of the peripheral arteries.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.